Japanese guidelines for allergic conjunctival diseases 2017

Allergology International - Tập 66 - Trang 220-229 - 2017
Etsuko Takamura1, Eiichi Uchio2, Nobuyuki Ebihara3, Shigeaki Ohno4, Yuichi Ohashi5, Shigeki Okamoto6, Naoki Kumagai7, Yoshiyuki Satake8, Jun Shoji9, Yayoi Nakagawa10, Kenichi Namba4, Kazumi Fukagawa11,12, Atsuki Fukushima13, Hiroshi Fujishima14
1Department of Ophthalmology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan
2Department of Ophthalmology, Fukuoka University, School of Medicine, Fukuoka, Japan
3Department of Ophthalmology, Juntendo University, Urayasu Hospital, Chiba, Japan
4Department of Ophthalmology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan
5Department of Ophthalmology, Ehime University School of Medicine, Ehime, Japan
6Okamoto Eye Clinic, Ehime, Japan
7Kumagai Eye Clinic, Yamaguchi, Japan
8Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital, Chiba, Japan
9Division of Ophthalmology, Department of Visual Sciences, Nihon University School of Medicine, Tokyo, Japan
10Nakagawa Eye Clinic, Osaka, Japan
11Ryogoku Eye Clinic, Tokyo, Japan
12Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan
13Department of Ophthalmology, Kochi Medical School, Kochi, Japan
14Department of Ophthalmology, Tsurumi University School of Dental Medicine, Kanagawa, Japan

Tài liệu tham khảo

Japanese Ocular Allergology Society, 2010, [Guidelines for the clinical management of allergic conjunctival disease (2nd edition)], Nippon Ganka Gakkai Zasshi [J Jpn Ophthalmol Soc], 114, 831

Fukagawa, 2000, IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells, Int Arch Allergy Immunol, 121, 144, 10.1159/000024310

Kumagai, 2000, Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-3, Invest Ophthalmol Vis Sci, 41, 1448

Fukuda, 2003, Differential expression of thymus-and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung, J Allergy Clin Immunol, 111, 520, 10.1067/mai.2003.59

Nakagawa, 1988, [Conjunctival cytology], Nippon Ganka Kiyou [Folia Ophthalmol Jpn], 39, 200

Nakagawa, 2006, [Clinical evaluation of immunochromatography for measurement of total IgE concentration in tear fluid in allergic conjunctivitis], Rinsyo Ganka [Jpn J Clin Ophthalmol], 60, 951

Ohno, 2001, [New clinical evaluation standard and seriousness classification of allergic conjunctival diseases], Iyaku Journal [Med Drug J], 37, 1341

Armaly, 1965, Statistical attributes of steroid hypertensive response in the clinically normal eye, Invest Ophthalmol Vis Sci, 4, 187

Ohji, 1992, [Incidence of elevated intraocular pressure following topical corticosteroid in children], Rinsyo Ganka [Jpn J Clinic Ophthalmol], 46, 749

Ebihara, 2009, A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis, J Ocul Pharmacol Ther, 25, 365, 10.1089/jop.2008.0103

Ohashi, 2010, A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis, J Ocul Pharmacol Ther, 26, 165, 10.1089/jop.2009.0087

Juniper, 1994, Sodium cromoglycate eye drops: regular versus “as needed” use in the treatment of seasonal allergic conjunctivitis, J Allergy Clin Immunol, 94, 36, 10.1016/0091-6749(94)90069-8

Ebihara, 2003, [Treatment of allergic symptoms with pre-seasonal instillation of ibudilast], Atarasii Ganka [J Eye], 20, 259

Thông tin
Thông tin xuất bản

Allergology International

Tập 66

220-229

Thông tin tác giả